Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects
Clinical trial NCT03329573 · COMPLETED
Trial details
- NCT number
- NCT03329573
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-30
- Primary completion
- 2018-08-03
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.